v3.25.3
Condensed Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2023   24,554,000      
Beginning balance at Dec. 31, 2023 $ 105,195 $ 2 $ 374,129 $ 27 $ (268,963)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Share-based compensation expense 3,589   3,589    
Unrealized gain (loss) on investments, net of tax (35)     (35)  
Net Income (Loss) (18,289)       (18,289)
Ending balance (in shares) at Mar. 31, 2024   24,554,000      
Ending balance at Mar. 31, 2024 90,460 $ 2 377,718 (8) (287,252)
Beginning balance (in shares) at Dec. 31, 2023   24,554,000      
Beginning balance at Dec. 31, 2023 105,195 $ 2 374,129 27 (268,963)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Unrealized gain (loss) on investments, net of tax 12        
Net Income (Loss) (45,418)        
Ending balance (in shares) at Sep. 30, 2024   24,615,000      
Ending balance at Sep. 30, 2024 68,868 $ 2 383,208 39 (314,381)
Beginning balance (in shares) at Mar. 31, 2024   24,554,000      
Beginning balance at Mar. 31, 2024 90,460 $ 2 377,718 (8) (287,252)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Share-based compensation expense 2,839   2,839    
Issuance of shares under the employee stock purchase plan (in shares)   61,000      
Issuance of shares under the employee stock purchase plan 94   94    
Unrealized gain (loss) on investments, net of tax (19)     (19)  
Net Income (Loss) (14,583)       (14,583)
Ending balance (in shares) at Jun. 30, 2024   24,615,000      
Ending balance at Jun. 30, 2024 78,791 $ 2 380,651 (27) (301,835)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Share-based compensation expense 2,557   2,557    
Issuance of shares under the employee stock purchase plan 66        
Unrealized gain (loss) on investments, net of tax 66     66  
Net Income (Loss) (12,546)       (12,546)
Ending balance (in shares) at Sep. 30, 2024   24,615,000      
Ending balance at Sep. 30, 2024 $ 68,868 $ 2 383,208 39 (314,381)
Beginning balance (in shares) at Dec. 31, 2024 24,680,708 24,681,000      
Beginning balance at Dec. 31, 2024 $ 52,478 $ 2 385,114 16 (332,654)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Share-based compensation expense 1,680   1,680    
Issuance of common stock upon exercise of warrants (in shares)   426,000      
Issuance of common stock upon exercise of stock options (in shares)   22,000      
Issuance of common stock upon exercise of stock options 21   21    
Issuance of common stock in conjunction with vesting of restricted stock units (in shares)   63,000      
Private placement, net of transaction costs (in shares)   21,592,000      
Private placement, net of transaction costs 94,548 $ 2 94,546    
Unrealized gain (loss) on investments, net of tax (15)     (15)  
Net Income (Loss) 73,016       73,016
Ending balance (in shares) at Mar. 31, 2025   46,784,000      
Ending balance at Mar. 31, 2025 $ 221,728 $ 4 481,361 1 (259,638)
Beginning balance (in shares) at Dec. 31, 2024 24,680,708 24,681,000      
Beginning balance at Dec. 31, 2024 $ 52,478 $ 2 385,114 16 (332,654)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options (in shares) 24,936        
Unrealized gain (loss) on investments, net of tax $ 123        
Net Income (Loss) $ 2,655        
Ending balance (in shares) at Sep. 30, 2025 47,128,362 47,128,000      
Ending balance at Sep. 30, 2025 $ 157,168 $ 4 487,024 139 (329,999)
Beginning balance (in shares) at Mar. 31, 2025   46,784,000      
Beginning balance at Mar. 31, 2025 221,728 $ 4 481,361 1 (259,638)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Share-based compensation expense 3,087   3,087    
Issuance of common stock upon exercise of stock options (in shares)   3,000      
Issuance of common stock upon exercise of stock options 5   5    
Issuance of common stock in conjunction with vesting of restricted stock units (in shares)   325,000      
Private placement, net of transaction costs (171)   (171)    
Issuance of shares under the employee stock purchase plan (in shares)   16,000      
Issuance of shares under the employee stock purchase plan 24   24    
Unrealized gain (loss) on investments, net of tax 8     8  
Net Income (Loss) (52,615)       (52,615)
Ending balance (in shares) at Jun. 30, 2025   47,128,000      
Ending balance at Jun. 30, 2025 172,066 $ 4 484,306 9 (312,253)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Share-based compensation expense 2,718   2,718    
Unrealized gain (loss) on investments, net of tax 130     130  
Net Income (Loss) $ (17,746)       (17,746)
Ending balance (in shares) at Sep. 30, 2025 47,128,362 47,128,000      
Ending balance at Sep. 30, 2025 $ 157,168 $ 4 $ 487,024 $ 139 $ (329,999)